MPOX - USA (03): (CALIFORNIA) SAN FRANCISCO, CLADE I. The CDPH is monitoring the situation and e
Currently interpreted as supporting evidence for 2 tracked assessments.
Public note
For situational awareness and research transparency. Not medical advice.
System-generated assessment. This assessment remains under review until the stated horizon or until sufficient evidence allows evaluation.
Substantial confidence
Multiple lines of evidence are aligned, though the assessment remains provisional. Based on 8 linked evidence items and assessed against 90D.
02
The criteria the system uses to determine whether this assessment is borne out by the stated horizon.
Method
The condition the system checks for when evaluating this assessment.
Minimum source quality
Evidence must meet or exceed this credibility tier to count toward evaluation.
Required terms
california2026-07-19emergencyconfirmed03
Tracking since Apr 20, 2026.
06
The current analyst narrative for this scope.
Clade Ib multi-modal European spread continues; new research confirms MPXV replication in vaginal/ectocervical tissue, strengthening plausibility of non-sexual transmission routes.
No new CDPH announcement; CDC diagnostic pause continues
07
8 linked items.
Currently interpreted as supporting evidence for 2 tracked assessments.
Currently interpreted as supporting evidence for 2 tracked assessments.
Currently interpreted as supporting evidence for 2 tracked assessments.
Currently interpreted as supporting evidence for 7 tracked assessments.
Currently interpreted as supporting evidence for 12 tracked assessments.
Currently interpreted as supporting evidence for 8 tracked assessments.
This report is recorded in the evidence trail but is not yet linked to a tracked assessment.
This report is recorded in the evidence trail but is not yet linked to a tracked assessment.
Integrity anchor
Brier 0.202
19 resolved novel pathogen detection predictions.